Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia

Jill Fulcher,Philip Berardi,Grace Christou,Pierre J. A. Villeneuve,Christopher Bredeson,Mitchell Sabloff

LEUKEMIA & LYMPHOMA（2021）

引用 5|浏览9

暂无评分

摘要

T-Acute lymphoblast leukemia (T-ALL) accounts for 25-30% of adult ALL and occurs more frequently in young adults. Up to 35% of adults with T-ALL have a high-risk subtype called Early T-cell precurs...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要